BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 115.60
-2.60 (-2.20%)
Jul 24, 2026, 5:29 PM CET
BioGaia AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,581 | 1,538 | 1,423 | 1,297 | 1,104 | 785.11 |
Revenue Growth | 9.78% | 8.12% | 9.74% | 17.44% | 40.61% | 5.09% |
Gross Profit Gross Profit Growth | 1,154 | 1,129 | 1,031 | 950.19 | 801.93 | 582.95 |
Operating Income Operating Income Growth | 440.23 | 412.47 | 423.37 | 443.1 | 361.46 | 253.74 |
Net Income Net Income Growth | 164.66 | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Earnings Per Share EPS Growth | 3.43 | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 |
EPS Growth | 21.20% | -5.46% | -3.87% | -2.16% | 90.72% | -80.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pediatrics Pediatrics Growth | 1,178 | 1,154 | 1,093 | 1,014 | 868.36 | 603.69 |
Adult Health Adult Health Growth | 393.15 | 372.53 | 321.29 | 275.23 | 230.21 | 176.86 |
Other Segment Other Segment Growth | 9.55 | 11.62 | 8.15 | 7.75 | 5.4 | 4.57 |
Revenue (Total) Revenue (Total) Growth | 1,581 | 1,538 | 1,423 | 1,297 | 1,104 | 785.11 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 446.27 | 801.31 | 1,224 | 1,544 | 1,488 | 1,485 |
Total Debt Total Debt Growth | 0 | 0 | 0 | 0 | 0 | 0 |
Net Cash (Debt) Net Cash Growth | 446.27 | 801.31 | 1,224 | 1,544 | 1,488 | 1,485 |
Net Cash Growth | -28.29% | -34.53% | -20.74% | 3.75% | 0.25% | 1.14% |
Net Cash Per Share Net Cash Per Share Growth | 4.41 | 7.92 | 12.11 | 15.29 | 14.74 | 14.70 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 314.8 | 306.57 | 373.22 | 425.97 | 318.94 | 221.88 |
Capital Expenditures CapEx Growth | -15.13 | -3.52 | -13.76 | -48.57 | -17.92 | -6.38 |
Free Cash Flow Free Cash Flow Growth | 299.67 | 303.04 | 359.46 | 377.4 | 301.03 | 215.5 |
Free Cash Flow Growth | -3.50% | -15.70% | -4.75% | 25.37% | 39.69% | 5.03% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.01% | 73.37% | 72.45% | 73.29% | 72.64% | 74.25% |
Operating Margin | 27.85% | 26.82% | 29.76% | 34.18% | 32.74% | 32.32% |
Pretax Margin | 28.12% | 27.38% | 31.48% | 36.16% | 40.55% | 32.19% |
Profit Margin | 21.97% | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% |
FCF Margin | 18.96% | 19.70% | 25.27% | 29.11% | 27.27% | 27.45% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.000 | 1.640 | 1.950 | 1.900 | 1.450 | 0.730 |
Dividend Per Share Growth | -42.03% | -15.90% | 2.63% | 31.03% | 98.63% | 7.04% |
Dividend Yield | 3.46% | 6.50% | 6.16% | 2.87% | 3.57% | 3.29% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 33.71 | 32.28 | 32.16 | 27.96 | 22.59 | 10.68 |
Forward PE | 27.15 | 27.23 | 29.29 | 26.42 | 29.95 | 50.89 |
P/FCF Ratio | 39.02 | 35.45 | 31.49 | 27.08 | 28.03 | 9.71 |
PS Ratio | 7.40 | 6.98 | 7.96 | 7.88 | 7.64 | 2.67 |